Department of Nephrology, The Third Affiliated Hospital of Sun Yat-Sen University, Tianhe Road 600#, Guangzhou, 510630, PR China.
Int Urol Nephrol. 2021 Feb;53(2):333-341. doi: 10.1007/s11255-020-02657-x. Epub 2020 Oct 6.
To investigate the association of clinical and histological characteristics and the development of ESRD in T2DM patients with renal involvement.
We conducted a retrospective analysis of clinical and pathologic data from T2DM patients who underwent renal biopsy (n = 120).
The mean age, duration of diabetes, and eGFR were 50.9 ± 11.2 years, 92.8 ± 41.3 months, 55.1 ± 42.3 mL/min/1.73 m, respectively. Among these patients, 57 (47.5%) were diagnosed with diabetic nephropathy (DN), and 63 (52.5%) with non-diabetic renal disease (NDRD). The most common subtype of NDRD is membranous nephropathy. Compared with the NDRD group, the DN group had a longer duration of diabetes, worse renal function, and a higher proportion of diabetic retinopathy. Kaplan-Meier analysis showed that the 5-year renal survival rate of the DN group was only 41%, whereas that of the NDRD group was 84%. ESRD was defined as eGFR below 15 mL/min/1.73 m. After multivariate adjustment, the risk of ESRD in DN patients was 3.81 times higher than that in NDRD patients. According to Glomerular Class, the 5-year renal survival rate of type IIA, IIB, III, and IV in the DN group was 88, 56, 28, and 15%, respectively. Kaplan-Meier analysis showed that there was a significant difference in renal survival among different glomerular classes or different interstitial fibrosis and tubular atrophy (IFTA) scores. But Cox proportional hazards analysis indicated that only IFTA score (HR 2.75, 95% CI 1.37-5.51, P = 0.001), but not the glomerular class (HR 1.21, 95% CI 0.73-2.00, P = 0.465), could predict renal outcome when adjusting for multivariate.
The prognosis of DN patients is significantly worse than that of NDRD patients. Compared with glomerular lesions, tubulointerstitial lesions were associated with higher risk for renal death in DN patients.
探讨 T2DM 患者肾脏受累时临床和组织学特征与 ESRD 发展的关系。
我们对 120 例行肾活检的 T2DM 患者的临床和病理资料进行了回顾性分析。
患者的平均年龄、糖尿病病程和 eGFR 分别为 50.9±11.2 岁、92.8±41.3 个月和 55.1±42.3 mL/min/1.73 m。其中 57 例(47.5%)诊断为糖尿病肾病(DN),63 例(52.5%)为非糖尿病性肾脏疾病(NDRD)。NDRD 最常见的亚型是膜性肾病。与 NDRD 组相比,DN 组的糖尿病病程更长,肾功能更差,糖尿病视网膜病变的比例更高。Kaplan-Meier 分析显示,DN 组的 5 年肾脏生存率仅为 41%,而 NDRD 组为 84%。ESRD 定义为 eGFR<15 mL/min/1.73 m。多变量调整后,DN 患者发生 ESRD 的风险是 NDRD 患者的 3.81 倍。根据肾小球分级,DN 组的 5 年肾脏生存率在 IIA、IIB、III 和 IV 型分别为 88%、56%、28%和 15%。Kaplan-Meier 分析显示,不同肾小球分级或不同间质纤维化和肾小管萎缩(IFTA)评分之间的肾脏生存率存在显著差异。但 Cox 比例风险分析表明,只有 IFTA 评分(HR 2.75,95%CI 1.37-5.51,P=0.001),而不是肾小球分级(HR 1.21,95%CI 0.73-2.00,P=0.465),可以在调整多变量后预测肾脏结局。
DN 患者的预后明显差于 NDRD 患者。与肾小球病变相比,DN 患者的肾小管间质病变与更高的肾脏死亡风险相关。